Selected research
Market Outlook & Growth Opportunities
Global Benchtop Sequencers Market Outlook and Growth Opportunities 2026
Market perspective
The global Benchtop Sequencers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Benchtop Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Benchtop Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Benchtop Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Benchtop Sequencers market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Benchtop Sequencers market include Illumina, ELEMENT BIOSCIENCES, CD Genomics, Singular Genomics Systems, Spectrum, Thermo Fisher, QIAGEN, Perkin Elmer and Agilent Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Benchtop Sequencers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Benchtop Sequencers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Benchtop Sequencers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Benchtop Sequencers market size, projected growth trends, production technologies, key applications, and end-use industries.
Benchtop Sequencers Segment by Company
Illumina
ELEMENT BIOSCIENCES
CD Genomics
Singular Genomics Systems
Spectrum
Thermo Fisher
QIAGEN
Perkin Elmer
Agilent Technologies
Tecan
Beckman Coulter
INTEGRA Biosciences AG
AUTOMATA
Difei Medical Technology (Nanjing)
Hangzhou Matridx Biotechnology
Shanghai 3D Medicines
MobiDrop (Zhejiang)
GUANGDONG MGI TECH
Benchtop Sequencers Segment by Type
DNA Library Preparation
RNA Library Preparation
ChIP Library Preparation
Benchtop Sequencers Segment by Application
Clinical Testing
Scientific Research
Benchtop Sequencers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Benchtop Sequencers status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Benchtop Sequencers market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Benchtop Sequencers significant trends, drivers, influence factors in global and regions.
6. To analyze Benchtop Sequencers competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Benchtop Sequencers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Benchtop Sequencers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Benchtop Sequencers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Benchtop Sequencers market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Benchtop Sequencers industry.
Chapter 3: Detailed analysis of Benchtop Sequencers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Benchtop Sequencers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Benchtop Sequencers in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Library Preparation
- RNA Library Preparation
- ChIP Library Preparation
Applications
- Clinical Testing
- Scientific Research
Companies covered
- Illumina
- ELEMENT BIOSCIENCES
- CD Genomics
- Singular Genomics Systems
- Spectrum
- Thermo Fisher
- QIAGEN
- Perkin Elmer
- Agilent Technologies
- Tecan
- Beckman Coulter
- INTEGRA Biosciences AG
- AUTOMATA
- Difei Medical Technology (Nanjing)
- Hangzhou Matridx Biotechnology
- Shanghai 3D Medicines
- MobiDrop (Zhejiang)
- GUANGDONG MGI TECH
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Benchtop Sequencers Sales Value (2021-2032)
- 1.2.2 Global Benchtop Sequencers Sales Volume (2021-2032)
- 1.2.3 Global Benchtop Sequencers Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Benchtop Sequencers Market Dynamics
- 2.1 Benchtop Sequencers Industry Trends
- 2.2 Benchtop Sequencers Industry Drivers
- 2.3 Benchtop Sequencers Industry Opportunities and Challenges
- 2.4 Benchtop Sequencers Industry Restraints
3 Benchtop Sequencers Market by Company
- 3.1 Global Benchtop Sequencers Company Revenue Ranking in 2025
- 3.2 Global Benchtop Sequencers Revenue by Company (2021-2026)
- 3.3 Global Benchtop Sequencers Sales Volume by Company (2021-2026)
- 3.4 Global Benchtop Sequencers Average Price by Company (2021-2026)
- 3.5 Global Benchtop Sequencers Company Ranking (2024-2026)
- 3.6 Global Benchtop Sequencers Company Manufacturing Base and Headquarters
- 3.7 Global Benchtop Sequencers Company Product Type and Application
- 3.8 Global Benchtop Sequencers Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Benchtop Sequencers Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Benchtop Sequencers Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Benchtop Sequencers Market by Type
- 4.1 Benchtop Sequencers Type Introduction
- 4.1.1 DNA Library Preparation
- 4.1.2 RNA Library Preparation
- 4.1.3 ChIP Library Preparation
- 4.2 Global Benchtop Sequencers Sales Volume by Type
- 4.2.1 Global Benchtop Sequencers Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Benchtop Sequencers Sales Volume by Type (2021-2032)
- 4.2.3 Global Benchtop Sequencers Sales Volume Share by Type (2021-2032)
- 4.3 Global Benchtop Sequencers Sales Value by Type
- 4.3.1 Global Benchtop Sequencers Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Benchtop Sequencers Sales Value by Type (2021-2032)
- 4.3.3 Global Benchtop Sequencers Sales Value Share by Type (2021-2032)
5 Benchtop Sequencers Market by Application
- 5.1 Benchtop Sequencers Application Introduction
- 5.1.1 Clinical Testing
- 5.1.2 Scientific Research
- 5.2 Global Benchtop Sequencers Sales Volume by Application
- 5.2.1 Global Benchtop Sequencers Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Benchtop Sequencers Sales Volume by Application (2021-2032)
- 5.2.3 Global Benchtop Sequencers Sales Volume Share by Application (2021-2032)
- 5.3 Global Benchtop Sequencers Sales Value by Application
- 5.3.1 Global Benchtop Sequencers Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Benchtop Sequencers Sales Value by Application (2021-2032)
- 5.3.3 Global Benchtop Sequencers Sales Value Share by Application (2021-2032)
6 Benchtop Sequencers Regional Sales and Value Analysis
- 6.1 Global Benchtop Sequencers Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Benchtop Sequencers Sales by Region (2021-2032)
- 6.2.1 Global Benchtop Sequencers Sales by Region: 2021-2026
- 6.2.2 Global Benchtop Sequencers Sales by Region (2027-2032)
- 6.3 Global Benchtop Sequencers Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Benchtop Sequencers Sales Value by Region (2021-2032)
- 6.4.1 Global Benchtop Sequencers Sales Value by Region: 2021-2026
- 6.4.2 Global Benchtop Sequencers Sales Value by Region (2027-2032)
- 6.5 Global Benchtop Sequencers Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Benchtop Sequencers Sales Value (2021-2032)
- 6.6.2 North America Benchtop Sequencers Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Benchtop Sequencers Sales Value (2021-2032)
- 6.7.2 Europe Benchtop Sequencers Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Benchtop Sequencers Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Benchtop Sequencers Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Benchtop Sequencers Sales Value (2021-2032)
- 6.9.2 South America Benchtop Sequencers Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Benchtop Sequencers Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Benchtop Sequencers Sales Value Share by Country, 2025 VS 2032
7 Benchtop Sequencers Country-level Sales and Value Analysis
- 7.1 Global Benchtop Sequencers Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Benchtop Sequencers Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Benchtop Sequencers Sales by Country (2021-2032)
- 7.3.1 Global Benchtop Sequencers Sales by Country (2021-2026)
- 7.3.2 Global Benchtop Sequencers Sales by Country (2027-2032)
- 7.4 Global Benchtop Sequencers Sales Value by Country (2021-2032)
- 7.4.1 Global Benchtop Sequencers Sales Value by Country (2021-2026)
- 7.4.2 Global Benchtop Sequencers Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.9.2 France Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.16.2 China Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.19.2 India Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Benchtop Sequencers Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Benchtop Sequencers Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Benchtop Sequencers Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Illumina
- 8.1.1 Illumina Company Information
- 8.1.2 Illumina Business Overview
- 8.1.3 Illumina Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Illumina Benchtop Sequencers Product Portfolio
- 8.1.5 Illumina Recent Developments
- 8.2 ELEMENT BIOSCIENCES
- 8.2.1 ELEMENT BIOSCIENCES Company Information
- 8.2.2 ELEMENT BIOSCIENCES Business Overview
- 8.2.3 ELEMENT BIOSCIENCES Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.2.4 ELEMENT BIOSCIENCES Benchtop Sequencers Product Portfolio
- 8.2.5 ELEMENT BIOSCIENCES Recent Developments
- 8.3 CD Genomics
- 8.3.1 CD Genomics Company Information
- 8.3.2 CD Genomics Business Overview
- 8.3.3 CD Genomics Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.3.4 CD Genomics Benchtop Sequencers Product Portfolio
- 8.3.5 CD Genomics Recent Developments
- 8.4 Singular Genomics Systems
- 8.4.1 Singular Genomics Systems Company Information
- 8.4.2 Singular Genomics Systems Business Overview
- 8.4.3 Singular Genomics Systems Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Singular Genomics Systems Benchtop Sequencers Product Portfolio
- 8.4.5 Singular Genomics Systems Recent Developments
- 8.5 Spectrum
- 8.5.1 Spectrum Company Information
- 8.5.2 Spectrum Business Overview
- 8.5.3 Spectrum Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Spectrum Benchtop Sequencers Product Portfolio
- 8.5.5 Spectrum Recent Developments
- 8.6 Thermo Fisher
- 8.6.1 Thermo Fisher Company Information
- 8.6.2 Thermo Fisher Business Overview
- 8.6.3 Thermo Fisher Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Thermo Fisher Benchtop Sequencers Product Portfolio
- 8.6.5 Thermo Fisher Recent Developments
- 8.7 QIAGEN
- 8.7.1 QIAGEN Company Information
- 8.7.2 QIAGEN Business Overview
- 8.7.3 QIAGEN Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.7.4 QIAGEN Benchtop Sequencers Product Portfolio
- 8.7.5 QIAGEN Recent Developments
- 8.8 Perkin Elmer
- 8.8.1 Perkin Elmer Company Information
- 8.8.2 Perkin Elmer Business Overview
- 8.8.3 Perkin Elmer Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Perkin Elmer Benchtop Sequencers Product Portfolio
- 8.8.5 Perkin Elmer Recent Developments
- 8.9 Agilent Technologies
- 8.9.1 Agilent Technologies Company Information
- 8.9.2 Agilent Technologies Business Overview
- 8.9.3 Agilent Technologies Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Agilent Technologies Benchtop Sequencers Product Portfolio
- 8.9.5 Agilent Technologies Recent Developments
- 8.10 Tecan
- 8.10.1 Tecan Company Information
- 8.10.2 Tecan Business Overview
- 8.10.3 Tecan Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Tecan Benchtop Sequencers Product Portfolio
- 8.10.5 Tecan Recent Developments
- 8.11 Beckman Coulter
- 8.11.1 Beckman Coulter Company Information
- 8.11.2 Beckman Coulter Business Overview
- 8.11.3 Beckman Coulter Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Beckman Coulter Benchtop Sequencers Product Portfolio
- 8.11.5 Beckman Coulter Recent Developments
- 8.12 INTEGRA Biosciences AG
- 8.12.1 INTEGRA Biosciences AG Company Information
- 8.12.2 INTEGRA Biosciences AG Business Overview
- 8.12.3 INTEGRA Biosciences AG Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.12.4 INTEGRA Biosciences AG Benchtop Sequencers Product Portfolio
- 8.12.5 INTEGRA Biosciences AG Recent Developments
- 8.13 AUTOMATA
- 8.13.1 AUTOMATA Company Information
- 8.13.2 AUTOMATA Business Overview
- 8.13.3 AUTOMATA Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.13.4 AUTOMATA Benchtop Sequencers Product Portfolio
- 8.13.5 AUTOMATA Recent Developments
- 8.14 Difei Medical Technology (Nanjing)
- 8.14.1 Difei Medical Technology (Nanjing) Company Information
- 8.14.2 Difei Medical Technology (Nanjing) Business Overview
- 8.14.3 Difei Medical Technology (Nanjing) Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Difei Medical Technology (Nanjing) Benchtop Sequencers Product Portfolio
- 8.14.5 Difei Medical Technology (Nanjing) Recent Developments
- 8.15 Hangzhou Matridx Biotechnology
- 8.15.1 Hangzhou Matridx Biotechnology Company Information
- 8.15.2 Hangzhou Matridx Biotechnology Business Overview
- 8.15.3 Hangzhou Matridx Biotechnology Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Hangzhou Matridx Biotechnology Benchtop Sequencers Product Portfolio
- 8.15.5 Hangzhou Matridx Biotechnology Recent Developments
- 8.16 Shanghai 3D Medicines
- 8.16.1 Shanghai 3D Medicines Company Information
- 8.16.2 Shanghai 3D Medicines Business Overview
- 8.16.3 Shanghai 3D Medicines Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Shanghai 3D Medicines Benchtop Sequencers Product Portfolio
- 8.16.5 Shanghai 3D Medicines Recent Developments
- 8.17 MobiDrop (Zhejiang)
- 8.17.1 MobiDrop (Zhejiang) Company Information
- 8.17.2 MobiDrop (Zhejiang) Business Overview
- 8.17.3 MobiDrop (Zhejiang) Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.17.4 MobiDrop (Zhejiang) Benchtop Sequencers Product Portfolio
- 8.17.5 MobiDrop (Zhejiang) Recent Developments
- 8.18 GUANGDONG MGI TECH
- 8.18.1 GUANGDONG MGI TECH Company Information
- 8.18.2 GUANGDONG MGI TECH Business Overview
- 8.18.3 GUANGDONG MGI TECH Benchtop Sequencers Sales, Value and Gross Margin (2021-2026)
- 8.18.4 GUANGDONG MGI TECH Benchtop Sequencers Product Portfolio
- 8.18.5 GUANGDONG MGI TECH Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Benchtop Sequencers Value Chain Analysis
- 9.1.1 Benchtop Sequencers Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Benchtop Sequencers Sales Mode & Process
- 9.2 Benchtop Sequencers Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Benchtop Sequencers Distributors
- 9.2.3 Benchtop Sequencers Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst